NCT00721955View on ClinicalTrials.gov

Staccato Loxapine in Agitated Patients With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Bipolar I Disorder
Interventions
DRUG

Inhaled Placebo

Inhaled loxapine Placebo, may repeat after 2 hours x 2

DRUG

Inhaled loxapine 5 mg

Inhaled Staccato loxapine 5 mg, may repeat after 2 hours x 2

DRUG

Inhaled loxapine 10 mg

Inhaled Staccato loxapine 10 mg, may repeat after 2 hours x 2

Trial Locations (6)

30308

Atlanta Center for Medical Research, Atlanta

77008

Claghorn-Lesem Research Clinic, Houston

78756

FutureSearch Trials, Austin

92025

Synergy Escondido, Escondido

92845

Collaborative NeuroScience Network, Inc., Garden Grove

98004

Northwest Clinical Research Center, Bellevue

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY